The detection of pathogens is important to the prevention and identification of health problems and for a better lifestyle. The advent of new technologies has brought in new and promising approach such as membrane filtering techniques, used mostly to separate the pathogens from food products another useful technique is antibody-labeled magnets. Progresses in DNA sequencing technology have made it possible to sequence complete microbial genomes efficiently and rapidly. Access to DNA sequences of complete microbial genomes provides new opportunities in designing innovative approaches for pathogen detection and in development of drug. New strategies are coming up for the prevention and treatment of chronic diseases from certain pathogens as etiologic agents. Several programs have been initiated for research and development of innovated and modern medicines and vaccines. Biomedical Advanced Research and Development Authority is an initiative by the U.S. Department of Health and Human Services; it provides systematic and integrated approach to the development and purchase of the drugs, vaccines, diagnostic tools and therapies necessary for medical emergencies involving blood borne pathogens such as Hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV (human immunodeficiency virus).
The growth of this market is chiefly credited to the high prevalence of infectious diseases, technological advances, growing concern for safety; government initiatives, bioterrorism surveillance and high healthcare expenditure are expected to provide the required impetus for the growth of this market. Innovation of products by association and continuous development in clinical researches are helping this market to soar. However, complicated regulatory framework, improper handling of instruments and expensive identification instruments and techniques are likely to hinder the growth of this market.
The pathogen identification and treatment market can be segmented on the basis of application, end-users and geography.
The application based pathogen identification and treatment market can be divided as biodefense, animal health care, food safety, diagnostics, pathology and clinical research. For biodefense or bioterrorism surveillance, precise analytical procedures for determining pathogenic agents are required. In animal health care community use of pathogen detection to develop numerous diagnostic tests, these are highly sensitive and reliable and for control and treatment of diseases of animals. In diagnostics, these methods are used to identify or detect toxins, infectious agents, metabolic disorders, parasites, and genetic susceptibility/resistance such as Arcanobacterium haemolyticum, Astrovirus, Baylisascaris, Clostridium difficile, Cytomegalovirus, Human bocavirus etc.
End users consists of clinical or diagnostic laboratories, hospitals, blood banks, pharmaceutical companies, biotechnological companies and culture collection repositories.
Geographically, pathogen identification and treatment market are categorized as North America, Europe, Asia Pacific, Latin America and Rest of the world.
There are major players in pathogen identification and treatment market are Abbott Laboratories, Achaogen, Inc., Alnylam Pharmaceuticals, Inc., Becton, Dickinson and Company, Biomérieux Sa, Charles River Laboratories Inc., Siemens Healthcare (subsidiary of Siemens AG), Sigma-Aldrich Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc. On the basis of clinical laboratories, the key players are listed as Bio-Imaging Technologies, Inc., Bio-Reference Laboratories, Inc., Quest Diagnostics, Neogenomics, RadNet, Inc.